Patent: 10,700,870
✉ Email this page to a colleague
Summary for Patent: 10,700,870
| Title: | Signature generation and verification system |
| Abstract: | Technologies are generally described for methods and devices for generating a final signature. The methods may comprise receiving a message by a processor. The methods may comprise generating a random number by a random number generator. The methods may comprise forwarding, by the processor, the random number to a cloaking element generator. The methods may comprise forwarding, by the processor, a private key to the cloaking element generator. The methods may comprise forwarding, by the processor, a group to the cloaking element generator. The methods may comprise forwarding, by the processor, a homomorphism to the cloaking element generator. The methods may comprise processing, by the cloaking element generator, the random number, the group, the private key, and the homomorphism to produce a cloaking element. The methods may comprise applying the cloaking element to transform the message into the final signature. |
| Inventor(s): | Anshel Iris, Goldfeld Dorian |
| Assignee: | VERIDIFY SECURITY INC. |
| Application Number: | US15816378 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,700,870
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | VPRIV | velaglucerase alfa | For Injection | 022575 | February 26, 2010 | 10,700,870 | 2037-11-17 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
